Cholestatic jaundice' (~h~j i s ' a we1 1 known and presumably-benign complication o f proionged PN. We now r e p o r t a preterm-infant i n whom f a t a l hepatocellular carcinoma (CA) occurred as a consequence o f b i l i a r y c i r r h o s i s secondary t o prolonged PN and PNassociated ChJ. The p a t i e n t was a 900 gram, 27-week gestation i n f a n t . Recurrent episodes o f necrotizing enterocol i t i s led t o small bowel resection and r e s u l t a n t short gut syndrome, necessit a t i n g PN f o r a t o t a l o f 395 days. During t h i s time progressive 1 i v e r dysfunction developed, w i t h marked conjugated hyperbil irubinemia (maximum 11.2 mg/dl), and increased transaminase levels. L i v e r biopsy a f t e r 112 days o f PN revealed p e r i p o r t a l f i b r o s i s a n d i n t r a c e l l u l a r cholestasis. A l l l i v e r function t e s t s were normal when discharged a t age 19 months. He was readmitted s i x months l a t e r w i t h fever, hepatomegaly, icterus, and melanotic stools, and expired a f t e r the onset o f massive GI hemorrhage. At autopsy, two separate hepatic tumor masses were found, one o f which had
Many preschool c h i l d r e n from low-income, Mexican-American fami l i e s have low growth percentiles. Biochemical evidence f o r i nadequate Zn n u t r i t i o n was found i n a group o f such c h i l d r e n i n Denver. The e f f e c t s o f Zn supplementation on growth v e l o c i t y and indices o f Zn n u t r i t i o n were examined i n a double-blind pairmatched control1 ed study. Children, 3-6 years o f age, were screened, w i t h parental consent i f height and weight were a t o r below the 10th percentile. I nclusion i n the study required an additional 2 o f the following: h a i r Zn 4 0 0 vg/g, plasma Zn <68 vg/dl, u r i n e Zn 4 0 0 pg/24hrs o r d i e t a r y Zn intake <2/3 o f RDA ( i .e. c6mgfday). P a r t i c i p a t i n g c h i l d r e n were assigned t o take d a i l y f o r 1 year e i t h e r 10 mg o f Zn as the s u l f a t e i n cherry syrup o r a placebo syrup. Growth v e l o c i t i e s were calculated from measurements obtained quarterly.
Height Increments i n cm/year (mean + S.D.)
Control
Zn Supplement p value Combined Sexes (13) 5.99 + 0.64 (12) 6.68 + 0.80 <0.025 Ma1 es ( 9) 5.87 t 0.33 ( 7)
6.39 + 0.60 S e q u e n t i a l blood l e v e l s of g l u c o s e , a l a n i n e , g l y c e r o l ( g l y ) l a c t a t e , pyuvate, 3-hydroxybutyrate (3HOB) Acetoacetate (AcOAc) a n d i n s u l i n were measured i n 1 6 i n f a n t s (mean b i r t h weight 2.81 kg, mean g e s t a t i o n a l age 37.9 weeks) r e c e i v i n g one of 2 regimens o f TPN, d e l i v e r i n g i d e n t i c a l c o n s t i t d e n t s (amino a c i d s (Vamin) 2.8 gm/kg/day, f a t ( I n t r a l i p i d ) 4.8 gm/kg/day, glucose 12 gm/kg/ d a y ) . 7 i n f a n t s who r e c e i v e d t h e n u t r i e n t s a s a continuous i n f u s i o n o f c o n s t a n t composition (continuous regimen, CR) had blood m e t a b o l i t e l e v e l s comparable t o t h o s e o f i n f a n t s fed e n t e ra l l y except f o r e l e v a t i o n o f i n s u l i n l e v e l (median 2 0 , range 2.5 -80 pU/ml).
<0.05 Females
9 i n f a n t s r e c e i v i n g t h e t o t a l d a i l y dose o f Vamin & i n t r a l i p i d t o g e t h e r over 10 hours followed by 10% glucose f o r 14 hours ( s e q u e n t i a l regimen, SR) had peak (median, range) blood S e v e r a l s t u d i e s have suggested t h a t LBW i n f a n t s f e d by t h e n a s o j e j u n a l (NJ) r o u t e gain weight more r a p i d l y than t h o s e f e d n a s o g a s t r i c a l l y (NG), d e s p i t e g r e a t e r f a t malabsorption during N J feeding.* 40 a p p r o p r i a t e l y grown LBW i n f a n t s (mean b i r t h weight 1.29 kg, range 1.04-1.49 kg; mean g e s t a t i o n a l age 29.6 weeks) were a l l o c a t e d t o continuous N J o r i n t e r m i t t e n t NG feedi n g a t b i r t h and t h e i r growth followed till 6 months a f t e r expected d a t e o f d e l i v e r y (EDDt6 months). I n f a n t s i n t h e N J group were t r a n s f e r r e d t o N G feeding when t h e y reached 1.5 kg bodyweight. Although mean (i1SD) e n t e r a l c a l o r i c i n t a k e i n t h e two groups was comparable (NJ 121.3f11.0; NG 121.7t9.6 cal/kg/day) mean (t1SD) weight v e l o c i t y d u r i n g N J feeding (11.4t3.6) was l e s s than during N G feeding (15.8i3.5 gm/kg/day, p=0.02), and bodyweight a t EDD was lower i n t h e N J group (mean weight index +1SD; N J group 0.89f0.04; N G gro,up 0.92t0.04; p<0.05). A f t e r t r a n s f e r t o N G feeding, i n f a n t s i n t h e N J group grew more r a p i d l y from EDD t o EDDt3 months (mean weight v e l o c i t y tlSD; N J group 7.69k1.57, N G group 6.49f1.59 gm/kg/day; p<0.05) s o t h a t a t EDDt3 months and EDD+6 months t h e r e was no s i g n i f i c a n t d i f f e r e n c e i n bodyweight between t h e two groups.
Because o f poorer weight g a i n during N J feeding, LBW i n f a n t s f e d by t h i s r o u t e from b i r t h should be t r a n s f e r r e d from N J feeding a s soon a s an adequate e n t e r a l c a l o r i e i n t a k e can be t o l e r a t e d by t h e NG r o u t e .
* and D.G. ~4 1 1 . GI Res. Unit, o f Calgary, Calgary, A l t a . TPN therapy has been associated w i t h cholestasis though the cause i s unknown. The e f f e c t o f TPN on b i l e formation was evaluated i n 10 studies performed i n three a d u l t dogs. The b i l e duct was d i r e c t l y cannulated v i a Thomas cannulas, while b i l e s a l t secretion was maintained by I V taurocholic acid infusion. A f t e r a 2 h basal ~e r i o d . e i t h e r an amino a c i d s o l u t i o n (2.5% Travasol) w i t h 10% glucose o r a l i p i d emulsion ( I n t r a l i p i d ) was added f o r 2 h followed by a second control period. Amino acid-glucose (AA) resulted i n a s i g n i f i c a n t increase i n b i l e flow (BF) which rose 33% while b i l e s a l t (BS) secretion increased t r a n s i e n t l y (11%) then returned t o basal l e v e l s (Table) . Cholesterol, phospholipid and b i l i r u b i n output d i d not change s i g n i f i c a n t l y .
Basal AA (h) Post AA 1 and AcOAc (195; 9i429) r e s p e c t i v e l y 1.8, 7 and 6 times g r e a t e r t h a n c o i n c i d e n t l e v e l s i n i n f a n t s r e c e i v i n g CR. Blood l e v e l s 
